PubMed · PMID 10944827
[Inhibitory effect of suplatast tosilate on eosinophil migration].
PMID 10944827Journal Arerugi = [Allergy]Year 2000Authors 4
Abstract
Suplatast tosilate has been shown to inhibit generation of Th2-type cytokines in vitro and used in the treatment of allergic diseases. Although the exact mechanism remains unknown, this compound attenuates the eosinophil infiltration in the asthmatic airway. In the present study, we examined whether suplatast tosilate directly modulates eosinophil migration in response to inflammatory mediators in vitro. Suplatast did not modify the spontaneous migration of eosinophils. On the other hand, eosinophil migration in response to PAF (1 microM) was significantly inhibited by 1 microM suplatast. Similarly, IL-5 (100 pM)-induced eosinophil migration was inhibited by 1 microM suplatast.
These results suggest that suplatast tosilate inhibits eosinophil locomotion in response to PAF or IL-5 and thereby attenuates infiltration of the cells in allergic inflammation.
Record details
| PMID | 10944827 |
|---|---|
| PMCID | not held |
| DOI | not stated |
| Journal | Arerugi = [Allergy] |
| Year | 2000 |
| Authors | Y Kobayashi; M Nagata; H Yamamoto; Y Sakamoto |
| Licence | not stated |
| MeSH | Anti-Allergic Agents; Arylsulfonates; Asthma; Cell Movement; Eosinophils; Histamine Antagonists; Humans; In Vitro Techniques; Interleukin-6; Platelet Activating Factor; Sulfonium Compounds |
Source record
Open the PubMed record. This page holds the abstract and citation fields for this PMID; no PMC full text is held for it.